TLC504 is a non-steroidal anti-inflammatory drug (NSAID) developed by TLC BioSciences, designed to provide pain relief with its innovative local anti-inflammatory and analgesic properties. Encapsulated in lipid nanoparticles (LNP), TLC504 ensures targeted delivery to inflamed tissues, offering a new level of precision in pain management. This advanced formulation aims to reduce systemic exposure and potential side effects, marking a significant advancement in therapeutic pain treatments.
Please select the unit you wish to search and enter the keyword in the text field below.